Immunomodulating role of bisphosphonates on human gamma delta T cells: an intriguing and promising aspect of their antitumour activity

Author： Galluzzo S   Santini D   Vincenzi B   Caccamo N   Meraviglia F   Salerno A   Dieli F   Tonini G  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.11, Iss.7, 2007-07, pp. : 941-954

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

uPA-anthrax toxin: promising antitumour activity

By  

Inpharma, Vol. 1, Iss. 1375, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Antitumour vaccine promising in glioblastoma

By  

Inpharma, Vol. 1, Iss. 1463, 2004-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Everolimus [RAD 001], in combination with octreotide long-acting repeatable (LAR), shows promising antitumour activity

By  

Inpharma, Vol. 1, Iss. 1657, 2008-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Antitumour Effects of Bisphosphonates: First Evidence and Possible Mechanisms

By Diel I.J.  

Drugs, Vol. 59, Iss. 3, 2000-03 ,pp. : 391-399

Adis International

Access to resources Recommend Favorite

The Role of the Adenosinergic Pathway in Immunosuppression Mediated by Human Regulatory T Cells (Treg)

By  

Current Medicinal Chemistry, Vol. 18, Iss. 34, 2011-12 ,pp. : 5217-5223

Bentham Science Publishers

Access to resources Recommend Favorite